{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:24:26Z","timestamp":1763058266054},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,10,15]]},"DOI":"10.2169\/internalmedicine.2790-19","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T18:03:33Z","timestamp":1561572213000},"page":"3009-3012","source":"Crossref","is-referenced-by-count":5,"title":["Pneumothorax as an Adverse Event in Patients with Lung Metastasis of Soft Tissue Sarcoma under Eribulin Treatment"],"prefix":"10.2169","volume":"58","author":[{"given":"Kohichi","family":"Takada","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Murase","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotaka","family":"Hayasaka","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Arihara","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Iyama","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Emori","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Division of Hospital Pharmacy, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Miyanishi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Kobune","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Judson I, Verweij J, Gelderblom H, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol 15: 415-423, 2014."},{"key":"2","unstructured":"2. Seddon B, Strauss SJ, Whelan J, et al. Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. Lancet Oncol 18: 1397-1410, 2017."},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. van der Graaf WT, Blay JY, Chawla SP, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 379: 1879-1886, 2012.","DOI":"10.1016\/S0140-6736(12)60651-5"},{"key":"4","unstructured":"4. Kawai A, Araki N, Sugiura H, et al. Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study. Lancet Oncol 16: 406-416, 2015."},{"key":"5","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(15)01283-0","volume":"387","author":"P Schoffski","year":"2016","unstructured":"5. Schoffski P, Chawla S, Maki RG, et al. Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet 387: 1629-1637, 2016.","journal-title":"The Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1186\/s12885-016-2786-z","volume":"16","author":"K Nakano","year":"2016","unstructured":"6. Nakano K, Motoi N, Tomomatsu J, et al. Risk factors for pneumothorax in advanced and\/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis. BMC Cancer 16: 750, 2016.","journal-title":"BMC Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"7","unstructured":"7. Verschoor AJ, Gelderblom H. Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series. Clin Sarcoma Res 4: 14, 2014."},{"key":"8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1186\/s12885-018-4858-8","volume":"18","author":"B Sabath","year":"2018","unstructured":"8. Sabath B, Muhammad HA, Balagani A, et al. Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study. BMC Cancer 18: 937, 2018.","journal-title":"BMC Cancer","ISSN":"http:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Hoag JB, Sherman M, Fasihudin Q, Lund ME. A comprehensive review of spontaneous pneumothorax complicating sarcoma. Chest 138: 510-518, 2010.","DOI":"10.1378\/chest.09-2292"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cortes J, Vahdat L, Blum JL, et al. Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine. J Clin Oncol 28: 3922-3928, 2010.","DOI":"10.1200\/JCO.2009.25.8467"},{"key":"11","unstructured":"11. Fiorelli A, Vicidomini G, Napolitano F, Santini M. Spontaneous pneumothorax after chemotherapy for sarcoma with lung metastases: case report and consideration of pathogenesis. J Thorac Dis 3: 138-140, 2011."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/20\/58_2790-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T23:34:17Z","timestamp":1571441657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/20\/58_2790-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":11,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2790-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]}}}